Below is the comparison between BBC and XBI. Below is the comparison between VHT and XBI. 08%. 67% Top 10 holdings are 16. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF. 99%. Search or filter ETFs by fund name, ticker, ISIN, or CUSIP, and browse for SPDR ETFs that align with your investment objectives. 2. Shares of XBI stock opened at $73. XBI is suitable for investors seeking to. 56% vs 0. Year-to-date, the SPDR S&P Biotech ETF has gained about 3. S. XBI: SPDR® S&P Biotech ETF: 1. View Holdings As of 09/30/2023. S&P Select Industry Indices are designed to measure the performance of narrow GICS® sub-industries. Looking at the chart above, XBI's low point in its 52 week range is $63. ETFs are subject to market fluctuation and the risks of their underlying investments. 88%. 58% and is down about -14. Search or filter ETFs by fund name, ticker, ISIN, or CUSIP, and browse for SPDR ETFs that align with your investment objectives. 06 and standard deviation of 38. 60 as the 52 week high point — that compares with a last trade of $70. 15 during this last 52-week period. Holdings AS OF 04/30/2023. 42 billion worth of. The XBI index methodology takes market cap and share liquidity into account in rebalancing holdings. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one. Free ratings, analyses, holdings, benchmarks, quotes, and news. 73% so far this year and is down about -39. The equal weight fund, designed to deliver. 6% of the fund. Latest Holdings, Performance, AUM (from 13F, 13D) XBI - SPDR (R) S&P (R) Biotech ETF has disclosed 142 total holdings in their latest SEC filings. 94 per share, with $121. 1%). No, even the large cap biotechs get pumped before a final FDA decision on a drug in their pipeline and usually have a sell off after on profit taking or a failed decision. 67. 50 -0. Total net assets. According to data from U. VHT has a lower expense ratio than XBI (0. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"),. VHT has a. Nearly half of its holdings are early-stage players with no drug on the market yet and that therefore. 38% vs. NBI IBBQ XBI BTK FBT IBB Other Topics Indexes Stocks ETFs Coronavirus Prableen Bajpai Prableen Bajpai is the founder of FinFix Research and. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. ARGX. XBI – SPDR® S&P Biotech ETF – Check XBI price, review total assets, see historical growth, and review the analyst rating from Morningstar. XBI has traded between. 79 as the 52 week high point — that compares with a last trade of $76. 97% of Total Assets) Name Symbol % Assets; BridgeBio Pharma Inc: BBIO: 2. View Holdings As of 08/31/2023. BTEK11. Taking a look at the XBI, it peaked at $174. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one. 73. IBB’s holdings include many leading biotech companies, with holdings capped at 8% on the five largest constituents and 4% for the remaining holdings. LABU has a lower 5-year return than XBI (-46. Below is the comparison between VHT and XBI. by Sweta Killa Published on September 18,2023. DLTR. 2B Total Assets 0. The top 10 holdings account for about 11. Find the latest iShares Biotechnology ETF (IBB) stock quote, history, news and other vital information to help you with your stock trading and investing. 18% and is down about -39. 66 +2. XBI has traded between $64. Viehbacher reported, “In the second quarter, Biogen continued to advance groundbreaking science with the FDA approval of two first-in-class therapies for Alzheimer’s disease and ALS, while also delivering on our. 35 %LABU: S&P Biotech Bull 3X Shares ETF:Finally, our fifth stock in our POWR Ratings/XBI combination strategy is Regeneron . Rated on Jun 30, 2023 Published on Jun 30. 27%. 2. XBI, MDGL, ARWR, CYTK: Large Inflows Detected at ETF. Discover historical prices for XBI stock on Yahoo Finance. Health Care Fund Highlights: 137 Total Holdings $5. ETFs - IBB, PBE, XBI. 24 per unit, that means that analysts see 75. Region Percentage; North, Central and South America: 99. Find Direxion Daily S&P Biotech Bull 3X Shares ETF (LABU) top 10 holdings and sector breakdown by %. ETF strategy - SPDR® S&P BIOTECH ETF - Current price data, news, charts and performanceSee the company profile for SPDR S&P Biotech ETF (XBI) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and. 26% rating in the component of Value. The company’s fifty day. ARKK ARKG. , Biogen Inc. The actual earnings estimates for the underlying holdings are provided by FactSet, First Call, I/B/E/S Consensus, and Reuters and are used to calculate a mean 3-5 year EPS growth rate estimate. 96 on December 31, 2021, to $83 per share at the end of 2022. 53 (3. 84%: Other: 0. BlackRock Files for Spot Ethereum ETF. A list of holdings for XBI (SPDR S&P BIOTECH ETF) with details about each stock and its percentage weighting in the ETF. Oct 10, 2022 01:14PM EDT. The Composition of the XBI is the Key. Immunovant Inc. Additionally. The XBI has been a leader beating other ETFs YTD, up about 35% until today. Free ratings, analyses, holdings, benchmarks, quotes, and news. XBI Holdings (Seeking Alpha) Risks. The beaten-down prices offer a solid buying opportunity for investors. TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks. The ETF return is roughly 4. 58%: Halozyme Therapeutics Inc:How To Invest / Fund Directory / ARK Genomic Revolution ETF vs SPDR S&P Biotech ETF . Across the 192 current stocks in the fund, all holdings have a weighting between 0. XBI has traded between $62. S. 84. 5% year-to-date and 38. IBB’s holdings include many leading biotech companies, with holdings capped at 8% on the five largest constituents and 4% for the remaining holdings. 57 billion. Learn everything about ROBO Global Healthcare Technology and Innovation ETF (HTEC). Looking at the chart above, XBI's low point in its 52 week range is $100. 97. Its fund flows were negative $259. 2, 2023. 81 and $134. LABU. 47 million over the past three months. The Direxion Daily S&P Biotech Bull and Bear 3X Shares seek daily investment results, before fees and expenses, of 300%, or 300% of the inverse (or opposite), of the performance of the S&P Biotechnology Select Industry Index. Netherlands. 47%. 22%: Revolution Medicines Inc Ordinary Shares: RVMD: 1. 00%) Most Recent Dividend 0. Fund Size Comparison. 50% vs. 15 billion assets under management. View the latest SPDR S&P Biotech ETF (XBI) stock price and news, and other vital information for better exchange traded fund investing. 1. 40 for Nov. Cryptocurrency. The index is equal-weighted so that smaller biotech stocks can make it into the portfolio. S. 06 as the 52 week high point — that compares with a last trade of $102. Performance and Risk. 86% so far this year and is down about -32. Better trading starts here. XBI (NYSE Ticker) Summary Prospectus-October 31, 2018. 66%. 77. 44 per share, with $92. 19%. Per cent of portfolio in top 5 holdings: 8. 2013. The weighted harmonic average of closing market price divided by. 01 to $0. 94 per share, with $121. The table below compares many ETF metrics between IBB and XBI. 79 as the 52 week high point — that compares with a last trade of $126. The fund employs an equal-weighted methodology, providing a balanced allocation across small, mid, and large-cap biotech companies. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where. View Top Holdings and Key Holding Information for iShares Biotechnology ETF (IBB). Unlock comprehensive insights, track historical transformations, and employ powerful tools for comparison and categorization, propelling you to stay ahead in your investment strategies. 61%) At close: 04:00PM EST Seeks to provide exposure to the Biotechnology segment of the S&P TMI, which comprises the following sub-industries: Biotechnology. Plus view geographic exposure, currency. The Global X Nasdaq 100 Covered Call ETF (QYLD) follows a “covered call” or “buy-write” strategy, in which the Fund buys the stocks in the Nasdaq 100 Index and “writes” or “sells” corresponding call options on the same index. 81 and $97. 45% and is down about -9. Royal Gold Inc. The biopharma industry has seen a recent upswing in mergers and acquisitions (M&A). Trade XBI with: Price/Earnings ttm 17. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (AMEX: XBI) where we have detected an. LABU has a higher expense ratio than XBI (1. 91 Billion . SPDR SERIES TRUST's SPDR (R) S&P (R) Biotech ETF (XBI) has disclosed 141 total holdings in their latest N-PORT filing with the SEC for the portfolio date of 2023-06-30. WIX. Published. 75M), Brown Advisory. The sale of ETFs is subject to an activity assessment fee (from $0. Both LABU and XBI are ETFs. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the SPDR S&P. 96%, and is down about -5. That's the main advantage to investing. 191), IBB is significantly more concentrated in its top ten holdings than XBI. It compares fees, performance, dividend yield, holdings, technical indicators, and many other metrics that help make better ETF investing. The ETF has a beta of 1. Its price to cash flow multiples is about 13. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. XBI, BEAM, FATE, NTLA: ETF Outflow Alert. November 03, 2023 — 10:50 am EDT. Performance and Risk. comSPDR S&P Biotech ETF is a equity fund issued by SSgA. 73m. 12% in the. 16bn USD. 79 as the 52 week high point — that compares with a last trade of $159. 78 per share, with $134. SPDR S&P Biotech ETF (XBI) NYSEArca - Nasdaq Real Time Price. 03 per $1,000 of principal). 35%). 95% for the trailing three-year period, which makes the fund a high risk choice in the space. 50 Bil, only including common equities, preferred equities, ETFs, options and warrants for equities. XBI, whose index recently expanded, also owns only a handful of established biotech companies. The top holding in XBI receives just a 1. This large ETF has performed well and is at its year highs, but will it continue to outperform? With takeover activity occurring in the sector, how will this ETF benefit? How is this ETF. S. ValueStrategy: Traditional value investing is an investment strategy where stocks are selected that trade for less than their intrinsic values. 09% of its total assets under management. Find SPDR® S&P Biotech ETF (XBI) top 10 holdings and sector breakdown by %. Market Capitalization. 47 million over the past three months. 50(-0. 1. The first column indicates the name of each of the funds holding XBI, with a link to that fund's top holdings. XBI SPDR S&P Biotech ETF ARKG ARK Genomic Revolution ETF IBB iShares Biotechnology ETF IHI iShares U. SPDR S&P Biotech ETF ( NYSEARCA: XBI) is likely in the early to mid stages of a period of underperformance, both versus its larger-cap peers and the broad US stock market. Visitors trend 2W 10W 9M. There are 10 biotech ETFs that trade in the United States,. Vertex Pharmaceuticals (VRTX 0. Learn everything about ROBO Global Healthcare Technology and Innovation ETF (HTEC). 2401 Millstream Rd 125 Victoria BC. The Global X Genomics & Biotechnology ETF (GNOM) seeks to invest in companies that potentially stand to benefit from further advances in the field of genomic science, such as companies involved in gene editing, genomic sequencing, genetic medicine/therapy, computational genomics, and biotechnology. The following charts reflect the geographic spread of WCLD's underlying holdings. 47 and a beta of 0. 47% vs -5. The fee is slightly higher for SBIO - . SPDR® S&P Biotech ETF (XBI) latest earnings report: revenue, EPS, surprise, history, news and analysis. Investo S&P Biotech Sel Industry ETF IE. News & World Report, XBI enjoys volume of 20. Find the latest quotes for SPDR S&P Biotech ETF (XBI) as well as ETF details, charts and news at Nasdaq. The S&P Biotechnology Select Industry Index comprises stocks in the S&P Total Market Index that are classified in the GICS Biotechnology sub-industry. 8% of its total assets under management. 72%: Data delayed at least 15 minutes, as of Nov 16 2023 21:00 GMT. I have thoroughly reviewed the holdings of the XBI and have come away impressed with how broad-based the composition of the ETF is. 1% which highlights the scope of the fund and diversification away from company-specific risks. Total healthcare and life sciences M&A was about $71. XBI: Head-To-Head ETF Comparison. 9. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. 86% upside for this ETF looking through to the average analyst targets of the underlying holdings. The top 10 holdings of XBI look like this: XBI Top 10 Holdings (morningstar. 5x and PE ratio is about 14x. Expense ratio and liquidity are average for the group. Jun 8, 2022 10:51AM EDT. 06 and standard deviation of 38. 06 as the 52 week high point — that compares with a last trade of $112. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF. Historical Price Data. ETF Constituents for S&P Biotech SPDR (XBI) provide detail on the individual stock holdings that make up the ETF. Expense ratio and liquidity are average for the group. We have highlighted five ETFs from different. As of the latest information, Bullfrog AI Holdings will launch its initial public offering ( IPO) — or the first time a private enterprise distributes its equity shares to retail (public. In addition to holding 155 positions, its top 10 holdings make up just 14. $72. XBI is one of a handful of biotech ETFs available, offering exposure to a corner of the market that can perform well during periods of consolidation and is capable of big jumps in the event of major drug approvals. Holdings: 266: Inception Date: Feb 5, 2001: About IBB Fund Home Page The iShares Biotechnology ETF (IBB) is an exchange-traded fund that is based on the NYSE Biotechnology index. A collar strategy is a protective option strategy constructed by writing a call and buying a put with the same expiration date while being long the underlying security. Message board - Online Community of active, educated investors researching and discussing Novavax Inc. Elevate your fund analysis with Holdings Data, allowing you to dive deeply into the intricacies of ETFs and Mutual Funds. XBI Portfolio - Learn more about the SPDR® S&P Biotech ETF investment portfolio including asset allocation, stock style,. 44 per share, with $92. Stock Analysis Chart Headlines Holdings Ownership Ratings. Trader's Guide 2024 Ships December 21st. Holdings. 64 billion, a PE ratio of 11. ARKK Holdings / CRSP / ARKK Holdings of CRISPR Therapeutics (CRSP) - Updated Daily. SPDR® S&P Biotech ETF (XBI) Stock Price, Quote, News & Analysis Save 45%! Get early access to our annual Black Friday Sale » XBI SPDR® S&P Biotech ETF. large-cap stocks. 7042%). 78% of XBI's total assets under management. In the institutional-holders-of-XBI table below, the initial column indicates the name of each top institutional holder of XBI, with a link to that fund's top holdings. The vast majority of XBI holdings have less. 97. It is gross of any fee waivers or expense reimbursements. 78% so far this year and in the past one year (as of 11/20/2023), respectively. Explore FBT for FREE on ETF Database: Price, Holdings, Charts, Technicals, Fact Sheet, News, and more. XBI holdings. 81% of the total fund's. 48%: Number of Holdings 78: Price/Book Ratio Price/Book Ratio. 1 Day NAV Change as of Nov 09, 2023. Meanwhile, XBI equal weights its holdings. Discover historical prices for XBI stock on Yahoo Finance. XBI, MDGL, SGEN, NTRA: ETF Outflow Alert. 18. Only one of these, AbbVie, is a. 7 days ago - Exploring Economic Indicators: Household Debt, Consumer Sentiment, and Trade - ETF Trends 14 days ago - What's Happening in the Labor Market? - ETF Trends ; 21 days ago - GDP Surges as Sentiment Slides: A Week of Economic Insights - ETF Trends 25 days ago - Consumer Discretionary vs. 35%). 37% in the last one. 36% of total assets under management. 88 ; Annual Dividend & Yield 0. 94 per share, with $174. 01 to $0. 56, which is an increase of 43. 71%: Number of Holdings 64: Price/Book Ratio Price/Book Ratio. Elevate your fund analysis with Holdings Data, allowing you to dive deeply into the intricacies of ETFs and Mutual Funds. $0. Written by BNK Invest for BNK Invest ->. Overview. 39M), JPMorgan Chase & Co. 01M), Whalerock Point Partners LLC ($343. Assets Under Management. 10(-0. SPDR S&P BIOTECH ETF. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the SPDR S&P. Share your ideas and get valuable insights from the community of like minded traders and investorsAlaunos Therapeutics, Inc. The top ten holdings have a 48. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. Get a real-time stock price quote for XBI (SPDR S&P BIOTECH ETF). Its top 10 holdings account for approximately 16. AMGN. 0. XBI has traded between $62. While this ETF allocates. Holdings. Find SPDR® S&P Biotech ETF (XBI) top 10 holdings and sector breakdown by %. It is gross of any fee waivers or expense reimbursements. Finally, our fifth stock in our POWR Ratings/XBI combination strategy is Regeneron (REGN). XBI, the SPDR S&P Biotech ETF, tracks the performance of the S&P Biotechnology Select Industry Index, offering exposure to the biotechnology sector. ETF Summary. 06 as the 52 week high point — that compares with a last trade of $102. Front end load. Most recent portfolio value is calculated to be $ 7,141,224,184 USD. 7% vs -5. $156. 35% ; Sectors:. Nearly half of its holdings are early-stage players with no drug on the market yet and that therefore. Also includes news, ETF details and other investing information. 04 per unit, that means that analysts see 73. 64 per share, with $174. Performance and Risk The ETF has lost about -9. The famed investor's Berkshire Hathaway (. 06 as the 52 week high point — that compares with a last trade of $109. The actual earnings estimates for the underlying holdings are provided by FactSet, First Call, I/B/E/S Consensus, and Reuters and are used to calculate a mean 3-5 year EPS growth rate estimate. IBB has 8. Currency in USD Follow 2W 10W 9M 72. 01% vs 0. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. 1. XBI Holdings 5 Beaten-Down ETFs to Buy Now. View Holdings As of 09/30/2023. XLY News. 80% of total assets under management. Free ratings, analyses, holdings, benchmarks, quotes, and news. Veeva Systems. In XBI, the top five holdings together represent only 9. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the SPDR S&P. View complete XBI exchange traded fund holdings for better informed ETF trading. Launched on 01/31/2006, the SPDR S&P Biotech ETF (XBI) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Biotech segment of the equity market. The firm has a market cap of $5. 9%: Israel: 3. The Global X Genomics & Biotechnology ETF (GNOM) seeks to invest in companies that potentially stand to benefit from further advances in the field of genomic science, such as companies involved in gene editing, genomic sequencing, genetic medicine/therapy, computational genomics, and biotechnology. XBI has a Diversified Portfolio. 51. 41% so far this year and in the past one year (as of 01/23/2023), respectively. Elevate your fund analysis with Holdings Data, allowing you to dive deeply into the intricacies of ETFs and Mutual Funds. 00. $6. Below is the comparison between ARKG and XBI. Holdings. m. Cryptocurrency. Unlock comprehensive insights, track historical transformations, and employ powerful tools for comparison and categorization, propelling you to stay ahead in your investment strategies. In addition, the recent spike in volatility has increased option prices even. $6. 3.